Related references
Note: Only part of the references are listed.Endothelial Microparticles From Acute Coronary Syndrome Patients Induce Premature Coronary Artery Endothelial Cell Aging and Thrombogenicity Role of the Ang II/AT1 Receptor/NADPH Oxidase-Mediated Activation of MAPKs and PI3-Kinase Pathways
Malak Abbas et al.
CIRCULATION (2017)
Replicative senescence promotes prothrombotic responses in endothelial cells: Role of NADPH oxidase- and cyclooxygenase-derived oxidative stress
Grazielle Caroline Silva et al.
EXPERIMENTAL GERONTOLOGY (2017)
The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
Sebastian Steven et al.
REDOX BIOLOGY (2017)
Antihyperglycemic agents and cardiovascular outcomes: recent insights
Harpreet S. Bajaj et al.
CURRENT OPINION IN CARDIOLOGY (2017)
The Redox-sensitive Induction of the Local Angiotensin System Promotes Both Premature and Replicative Endothelial Senescence: Preventive Effect of a Standardized Crataegus Extract
Sonia Khemais-Benkhiat et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2016)
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Glycemic Control with Ipragliflozin, a Novel Selective SGLT2 Inhibitor, Ameliorated Endothelial Dysfunction in Streptozotocin-Induced Diabetic Mouse
Hotimah Masdan Salim et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2016)
SGLT inhibitors attenuate NO-dependent vascular relaxation in the pulmonary artery but not in the coronary artery
Ying Han et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
Silvio E. Inzucchi et al.
DIABETES & VASCULAR DISEASE RESEARCH (2015)
Update of mortality attributable to diabetes for the IDF Diabetes Atlas: Estimates for the year 2013
DIABETES RESEARCH AND CLINICAL PRACTICE (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity
Matthias Oelze et al.
PLOS ONE (2014)
The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension
Florian Gembardt et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Hydrogen peroxide induces overexpression of angiotensin-converting enzyme in human umbilical vein endothelial cells
Xiaoqin Mu et al.
FREE RADICAL RESEARCH (2013)
Screening for type 2 diabetes and population mortality over 10 years
Chukwuemeka Nwaneri et al.
LANCET (2013)
Delphinidin-3-Glucoside Protects against Oxidized Low-Density Lipoprotein-Induced Mitochondrial Dysfunction in Vascular Endothelial Cells via the Sodium-Dependent Glucose Transporter SGLT1
Xin Jin et al.
PLOS ONE (2013)
Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences
Ivan Sabolic et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)
p53 Impairs Endothelial Function by Transcriptionally Repressing Kruppel-Like Factor 2
Ajay Kumar et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes
Muhammad A. Abdul-Ghani et al.
ENDOCRINE REVIEWS (2011)
Dose-Dependent Modulatory Effects of Insulin on Glucose-Induced Endothelial Senescence In Vitro and In Vivo: A Relationship between Telomeres and Nitric Oxide
Hisako Matsui-Hirai et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Endothelial Dysfunction: The Common Consequence in Diabetes and Hypertension
Wing Tak Wong et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
Certain Progestins Prevent the Enhancing Effect of 17 beta-Estradiol on NO-Mediated Inhibition of Platelet Aggregation by Endothelial Cells
Murielle Zerr-Fouineau et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease
Daniele Versari et al.
DIABETES CARE (2009)
Endothelial dysfunction and cardiovascular risk factors
Fernando Grover-Paez et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2009)
Reactive oxygen-derived free radicals are key to the endothelial dysfunction of diabetes
Yi Shi et al.
JOURNAL OF DIABETES (2009)
Angiotensin II induces endothelial cell senescence via the activation of mitogen-activated protein kinases
HaiYan Shan et al.
CELL BIOCHEMISTRY AND FUNCTION (2008)
Endothelial cellular senescence is inhibited by nitric oxide: Implications in atherosclerosis associated with menopause and diabetes
Toshio Hayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Calreticulin destabilizes glucose transporter-1 mRNA in vascular endothelial and smooth muscle cells under high-glucose conditions
H Totary-Jain et al.
CIRCULATION RESEARCH (2005)
Localization of the Na+-D-glucose cotransporter SGLT1 in the blood-brain barrier
K Elfeber et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2004)
Impaired nitric oxide synthase pathway in diabetes mellitus - Role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase
KY Lin et al.
CIRCULATION (2002)
Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes
C Cheetham et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells -: The potential role of transcription factor NF-κB
DY Li et al.
CIRCULATION (2000)
The impaired renal vasodilator response attributed to endothelium-derived hyperpolarizing factor in streptozotocin-induced diabetic rats is restored by 5-methyltetrahydrofolate
AS De Vriese et al.
DIABETOLOGIA (2000)
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
T Nishikawa et al.
NATURE (2000)
Share Paper
